Genetic Technologies Ltd has released a press release.
Non-Renounceable Rights Issue
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- Director Resignation
- Collaboration Agreement signed between GTG and TGen
- Reinstatement to Official Quotation
- Suspension from Official Quotation
- Quarterly Update and 4C
Later from Genetic Technologies
- Response to Appendix 3Y Query
- Genetype for Breast Cancer commissioned-Sales start Q1 2020
- Form F-1 Prospectus SEC Filing
- Updated Form F-1 Prospectus SEC Filing
- Breast Cancer Test US Sales Update
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies